Natixis’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $823K | Hold |
73,100
| – | – | ﹤0.01% | 622 |
|
|
2025
Q1 | $692K | Buy |
+73,100
| New | +$692K | ﹤0.01% | 598 |
|
|
2024
Q4 | – | Sell |
-73,101
| Closed | -$2.07M | – | 1077 |
|
|
2024
Q3 | $2.07M | Buy |
+73,101
| New | +$2.07M | 0.01% | 416 |
|
|
2024
Q2 | – | Sell |
-40,492
| Closed | -$1.33M | – | 1031 |
|
|
2024
Q1 | $1.33M | Buy |
+40,492
| New | +$1.33M | 0.01% | 470 |
|
|
2023
Q4 | – | Sell |
-15,157
| Closed | -$413K | – | 1061 |
|
|
2023
Q3 | $413K | Buy |
+15,157
| New | +$413K | ﹤0.01% | 624 |
|
|
2023
Q2 | – | Sell |
-2,611
| Closed | -$84.7K | – | 1043 |
|
|
2023
Q1 | $84.7K | Sell |
2,611
-20,000
| -88% | -$649K | ﹤0.01% | 787 |
|
|
2022
Q4 | $635K | Buy |
+22,611
| New | +$635K | ﹤0.01% | 632 |
|
|
2022
Q2 | – | Sell |
-7,059
| Closed | -$228K | – | 1113 |
|
|
2022
Q1 | $228K | Sell |
7,059
-163
| -2% | -$5.27K | ﹤0.01% | 1096 |
|
|
2021
Q4 | $200K | Sell |
7,222
-1,822
| -20% | -$50.5K | ﹤0.01% | 1177 |
|
|
2021
Q3 | $280K | Buy |
+9,044
| New | +$280K | ﹤0.01% | 1101 |
|
|
2020
Q3 | – | Sell |
-10,072
| Closed | -$72K | – | 798 |
|
|
2020
Q2 | $72K | Buy |
+10,072
| New | +$72K | ﹤0.01% | 713 |
|
|
2020
Q1 | – | Sell |
-45,437
| Closed | -$413K | – | 755 |
|
|
2019
Q4 | $413K | Sell |
45,437
-2,068
| -4% | -$18.8K | ﹤0.01% | 729 |
|
|
2019
Q3 | $342K | Sell |
47,505
-1,442
| -3% | -$10.4K | ﹤0.01% | 716 |
|
|
2019
Q2 | $389K | Buy |
48,947
+33,963
| +227% | +$270K | ﹤0.01% | 636 |
|
|
2019
Q1 | $187K | Buy |
14,984
+4,639
| +45% | +$57.9K | ﹤0.01% | 775 |
|
|
2018
Q4 | $206K | Buy |
+10,345
| New | +$206K | ﹤0.01% | 654 |
|
|
2018
Q3 | – | Sell |
-16,870
| Closed | -$355K | – | 863 |
|
|
2018
Q2 | $355K | Buy |
+16,870
| New | +$355K | ﹤0.01% | 737 |
|